David Suendermann Oeft
About David Suendermann Oeft
David Suendermann Oeft is the Chief Executive Officer of Modality.AI, with a PhD in Electrical Engineering and expertise in AI and signal processing. He has presented at multiple conferences and summits, focusing on digital biomarkers and AI technology in clinical trials and patient assessments.
Work at Modality.AI
David Suendermann Oeft serves as the Chief Executive Officer of Modality.AI, a company he co-founded in 2018. Under his leadership, the organization focuses on developing artificial intelligence technologies for remote patient monitoring and neurological assessments. His role involves overseeing the strategic direction of the company and ensuring the successful implementation of innovative solutions in healthcare.
Education and Expertise
David Suendermann Oeft holds a PhD in Electrical Engineering. His academic background provides a strong foundation for his expertise in artificial intelligence and signal processing. This knowledge is integral to his work in developing advanced technologies for patient assessments and monitoring.
Background
David Suendermann Oeft has a significant background in clinical research and technology development. He has participated in various summits and conferences, including the ALS Drug Development Summit and the Digital Biomarkers in Clinical Trials Summit. His involvement in these events highlights his commitment to advancing the field of digital health and biomarker research.
Achievements
David Suendermann Oeft has contributed to numerous scientific publications and presentations throughout his career. He has presented at notable events such as the 9th Clinical Trials Strategic Summit, the ENCALS Meeting in Stockholm, and the International Society for CNS Clinical Trials and Methodology. Additionally, he was interviewed by Bio.News regarding AI-based neurological assessments, showcasing his influence in the field.